Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
STRATTEC Security
STRT
$347M
| $1.66M | ﹤0.01% |
83,465
+19,100
| +30% | +$406K |
|
|
CVIA
2377
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $1.65M | ﹤0.01% |
818,499
+613,599
| +299% | +$1.14M |
|
|
ESXB
2378
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.65M | ﹤0.01% |
191,907
+1,500
| +0.8% | +$12K |
|
2379
Xylem
XYL
$28B
| $1.65M | ﹤0.01% |
20,700
-81,600
| -80% | -$6.41M |
|
2380
Peoples Bancorp of North Carolina
PEBK
$237M
| $1.65M | ﹤0.01% |
55,392
+9,800
| +21% | +$273K |
|
2381
Maui Land & Pineapple Co
MLP
$306M
| $1.64M | ﹤0.01% |
150,920
+6,420
| +4% | +$67.5K |
|
|
EBTC
2382
DELISTED
Enterprise Bancorp
EBTC
| $1.64M | ﹤0.01% |
54,552
+7,304
| +15% | +$215K |
|
|
AERI
2383
DELISTED
Aerie Pharmaceuticals
AERI
| $1.63M | ﹤0.01% |
+85,000
| New | +$1.95M |
|
2384
Bloom Energy
BE
$67.9B
| $1.63M | ﹤0.01% |
+501,765
| New | +$3.75M |
|
2385
Investar Holding Corp
ISTR
$425M
| $1.63M | ﹤0.01% |
68,360
+31,485
| +85% | +$740K |
|
2386
Larimar Therapeutics
LRMR
$448M
| $1.62M | ﹤0.01% |
182,552
+42,694
| +31% | +$468K |
|
2387
CRISPR Therapeutics
CRSP
$5.14B
| $1.61M | ﹤0.01% |
+39,300
| New | +$1.88M |
|
2388
Upwork
UPWK
$1.06B
| $1.61M | ﹤0.01% |
+121,100
| New | +$1.85M |
|
|
FRGI
2389
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.61M | ﹤0.01% |
154,466
+105,300
| +214% | +$1.1M |
|
2390
Fulton Financial
FULT
$4.72B
| $1.61M | ﹤0.01% |
99,445
-213,800
| -68% | -$3.48M |
|
|
VBTX
2391
DELISTED
Veritex Holdings
VBTX
| $1.61M | ﹤0.01% |
66,295
+12,400
| +23% | +$305K |
|
2392
Coastal Financial
CCB
$788M
| $1.61M | ﹤0.01% |
+106,443
| New | +$1.62M |
|
2393
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.61M | ﹤0.01% |
57,100
+16,500
| +41% | +$420K |
|
|
ATSG
2394
DELISTED
Air Transport Services Group
ATSG
| $1.61M | ﹤0.01% |
76,400
+19,200
| +34% | +$419K |
|
2395
Ceco Environmental
CECO
$4.62B
| $1.6M | ﹤0.01% |
229,683
-58,600
| -20% | -$468K |
|
2396
Protolabs
PRLB
$2.17B
| $1.6M | ﹤0.01% |
+15,700
| New | +$1.6M |
|
|
TBHC
2397
DELISTED
The Brand House Collective
TBHC
| $1.6M | ﹤0.01% |
1,037,300
+269,200
| +35% | +$418K |
|
2398
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.42B
| $1.59M | ﹤0.01% |
49,300
+22,200
| +82% | +$701K |
|
2399
Colony Bankcorp
CBAN
$470M
| $1.59M | ﹤0.01% |
103,811
-1,489
| -1% | -$24K |
|
2400
First United
FUNC
$294M
| $1.58M | ﹤0.01% |
72,002
+28,902
| +67% | +$609K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.